Home›Companies›Biotech & Pharma›Rapalogix Health

Rapalogix Health, Inc.

Develops skincare products and prescription treatments for people with skin concerns.

Updated Nov 10, 2026·Latest SEC filing Jun 26, 2026·Suggest an edit

About Rapalogix Health

Rapalogix Health is a private company based in Carlsbad, California, incorporated in 2023 in Delaware. It has reported $28,192,362 raised in two offerings on Form D since January 2024. Its chief executive is Rahul Mehta.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 22, 2026Jun 26, 2026$19,112,746of $24.9M target28$682KEquityRule 506(b)Form D ↗
Dec 22, 2023Jan 17, 2024amended Jun 4, 2025$9,079,616of $13.5M target24$378KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$28,192,362

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Rapalogix Health's Form D filed Jun 26, 2026.

Rahul Mehta
Rahul Mehta
Co-Founder & Chief Executive Officer
JH
Juliette Han
Board Member & Secretary
Also an executive officer and director at Cambrian Bio.
Brent Saunders
Brent Saunders
Co-Founder & Board Member
DD
Doris Day
Co-Founder & Board Member
James Peyer
James Peyer
Co-Founder & Board Chair
Also CEO, Founder, Board Director at Cambrian Bio.
David Nicholson
David Nicholson
Board Member
Craig Gordon
Craig Gordon
Board Member
Also a director at Amlogenyx.

Earlier filings also listed Joan Mannick (director, last listed Jun 2025).

Sources

  1. SECRapalogix Health, Inc. Form D, filed Jan 17, 2024
  2. SECRapalogix Health, Inc. filing history
  3. CompanyAbout Rapalogix Health
  4. CompanySeries A announcement